title: Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison--response.
authors.affiliation: Department of Ophthalmology, Kasr El Aini Hospitals, Cairo University, Cairo, Egypt.
authors.forename: Ahmed S
authors.initials: AS
authors.lastname: Gado
authors.affiliation: Department of Ophthalmology, Kasr El Aini Hospitals, Cairo University, Cairo, Egypt.
authors.forename: Tamer A
authors.initials: TA
authors.lastname: Macky
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003907:Dexamethasone / Q000008:administration & dosage*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D008269:Macular Edema / Q000188:drug therapy*; D008297:Male; D012170:Retinal Vein Occlusion / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D005938:Glucocorticoids; D003907:Dexamethasone